290 related articles for article (PubMed ID: 32310272)
1. Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts.
Tuvshintulga B; Vannier E; Tayebwa DS; Gantuya S; Sivakumar T; Guswanto A; Krause PJ; Yokoyama N; Igarashi I
J Infect Dis; 2020 Aug; 222(6):1027-1036. PubMed ID: 32310272
[TBL] [Abstract][Full Text] [Related]
2. Combination of Clofazimine and Atovaquone as a Potent Therapeutic Regimen for the Radical Cure of Babesia microti Infection in Immunocompromised Hosts.
Tuvshintulga B; Sivakumar T; Nugraha AB; Ahedor B; Batmagnai E; Otgonsuren D; Liu M; Xuan X; Igarashi I; Yokoyama N
J Infect Dis; 2022 Jan; 225(2):238-242. PubMed ID: 34664651
[TBL] [Abstract][Full Text] [Related]
3. Emergence of resistance to azithromycin-atovaquone in immunocompromised patients with Babesia microti infection.
Wormser GP; Prasad A; Neuhaus E; Joshi S; Nowakowski J; Nelson J; Mittleman A; Aguero-Rosenfeld M; Topal J; Krause PJ
Clin Infect Dis; 2010 Feb; 50(3):381-6. PubMed ID: 20047477
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 4-kinase is a viable target for the radical cure of
Ji S; Galon EM; Amer MM; Zafar I; Yanagawa M; Asada M; Zhou J; Liu M; Xuan X
Front Cell Infect Microbiol; 2022; 12():1048962. PubMed ID: 36452305
[TBL] [Abstract][Full Text] [Related]
5. Could the Drug Tafenoquine Revolutionize Treatment of Babesia microti Infection?
Mordue DG; Wormser GP
J Infect Dis; 2019 Jul; 220(3):442-447. PubMed ID: 31099380
[TBL] [Abstract][Full Text] [Related]
6. Screening for biomarkers reflecting the progression of Babesia microti infection.
Xu B; Liu XF; Cai YC; Huang JL; Zhang RX; Chen JH; Cheng XJ; Zhou X; Xu XN; Zhou Y; Zhang T; Chen SB; Li J; Wu QF; Sun CS; Fu YF; Chen JX; Zhou XN; Hu W
Parasit Vectors; 2018 Jul; 11(1):379. PubMed ID: 29970143
[TBL] [Abstract][Full Text] [Related]
7. Elimination of
Skariah S; Arnaboldi P; Dattwyler RJ; Sultan AA; Gaylets C; Walwyn O; Mulhall H; Wu X; Dargham SR; Mordue DG
J Immunol; 2017 Jul; 199(2):633-642. PubMed ID: 28607116
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of inhibitory effect of redox-active antimalarial drug against Babesia microti in mice.
Szymczak J; Kozłowska J; Doligalska M
Ann Parasitol; 2017; 63(3):223–227. PubMed ID: 29274217
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the Antimalarial MMV390048 against
Ji S; Galon EM; Rizk MA; Yi Y; Zafar I; Li H; Ma Z; Iguchi A; Asada M; Liu M; Xuan X
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0057422. PubMed ID: 35924942
[TBL] [Abstract][Full Text] [Related]
10. Clofazimine Inhibits the Growth of Babesia and Theileria Parasites In Vitro and In Vivo.
Tuvshintulga B; AbouLaila M; Davaasuren B; Ishiyama A; Sivakumar T; Yokoyama N; Iwatsuki M; Otoguro K; Ōmura S; Igarashi I
Antimicrob Agents Chemother; 2016 May; 60(5):2739-46. PubMed ID: 26883713
[TBL] [Abstract][Full Text] [Related]
11. Age-Related Differential Stimulation of Immune Response by
Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
Front Immunol; 2018; 9():2891. PubMed ID: 30619263
[TBL] [Abstract][Full Text] [Related]
12. HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes.
Schwake C; Baldwin MR; Bachovchin W; Hegde S; Schiemer J; Okure C; Levin AE; Vannier E; Hanada T; Chishti AH
Biochem Biophys Res Commun; 2019 Sep; 517(1):125-131. PubMed ID: 31311649
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of 19 antiprotozoal drugs and antibiotics on Babesia microti infection in BALB/c mice.
Yao JM; Zhang HB; Liu CS; Tao Y; Yin M
J Infect Dev Ctries; 2015 Sep; 9(9):1004-10. PubMed ID: 26409742
[TBL] [Abstract][Full Text] [Related]
14. Transmission risk evaluation of transfusion blood containing low-density
Cai Y; Xu B; Liu X; Yang W; Mo Z; Zheng B; Chen J; Hu W
Front Cell Infect Microbiol; 2024; 14():1334426. PubMed ID: 38375363
[TBL] [Abstract][Full Text] [Related]
15. Human babesiosis: Indication of a molecular mimicry between thrombospondin domains from a novel Babesia microti BmP53 protein and host platelets molecules.
Mousa AA; Roche DB; Terkawi MA; Kameyama K; Kamyingkird K; Vudriko P; Salama A; Cao S; Orabi S; Khalifa H; Ahmed M; Attia M; Elkirdasy A; Nishikawa Y; Xuan X; Cornillot E
PLoS One; 2017; 12(10):e0185372. PubMed ID: 29040286
[TBL] [Abstract][Full Text] [Related]
16. Roles of the Maltese cross form in the development of parasitemia and protection against Babesia microti infection in mice.
Yokoyama N; Bork S; Nishisaka M; Hirata H; Matsuo T; Inoue N; Xuan X; Suzuki H; Sugimoto C; Igarashi I
Infect Immun; 2003 Jan; 71(1):411-7. PubMed ID: 12496191
[TBL] [Abstract][Full Text] [Related]
17. Impact of Babesia microti infection on the initiation and course of pregnancy in BALB/c mice.
Tołkacz K; Rodo A; Wdowiarska A; Bajer A; Bednarska M
Parasit Vectors; 2021 Mar; 14(1):132. PubMed ID: 33653384
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of the experimental animal model of Babesia microti].
Lu Y; Cai YC; Chen SH; Chen JX; Guo J; Chen MX; Ai L; Chu YH; Chen Z; Zhou XN
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Dec; 30(6):423-7. PubMed ID: 23484250
[TBL] [Abstract][Full Text] [Related]
19. Utilization of a real-time PCR assay for diagnosis of Babesia microti infection in clinical practice.
Wang G; Wormser GP; Zhuge J; Villafuerte P; Ip D; Zeren C; Fallon JT
Ticks Tick Borne Dis; 2015 Apr; 6(3):376-82. PubMed ID: 25819568
[TBL] [Abstract][Full Text] [Related]
20. Age-associated decline in resistance to Babesia microti is genetically determined.
Vannier E; Borggraefe I; Telford SR; Menon S; Brauns T; Spielman A; Gelfand JA; Wortis HH
J Infect Dis; 2004 May; 189(9):1721-8. PubMed ID: 15116311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
